Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ILLINOIS RETINA ASSOCIATES

Home Clinical Trial Sponsors and OrganizationsILLINOIS RETINA ASSOCIATES

ILLINOIS RETINA ASSOCIATES

300 Barney Dr Ste D, Joliet, Illinois, United Stateswww.illinoisretina.comEstablished: 1976-01-01

Also known as:

retina center

retina center, the

hasan sohail j

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

3

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1976

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 4

2

66.7%

Phase 3

1

33.3%

Trial Status Distribution

Completed

3

100.0%

Clinical Trials

Trials sponsored by this organization (3)

Patient Assessment of Topical Anesthetic Effectiveness for Intravitreal Injections

Oct 2009120 participants

Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections

Aug 200822 participants

Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment

Feb 200710 participants

Approvals

No approval data available

News

Pykus Therapeutics Completes Enrollment for Novel Retinal Detachment Treatment Trial

- Pykus Therapeutics has completed enrollment for its PYK-2101 pilot study in Australia, testing a first-in-class biodegradable retinal hydrogel sealant for retinal detachment surgery. - The innovative treatment aims to eliminate the need for post-operative face-down positioning and intraocular gas, potentially transforming patient recovery and surgical outcomes. - The company plans to submit an Investigational Device Exemption application to the FDA in Q4 2025 for a U.S. pivotal trial, with interim study results expected in Q2 2025.

On this page

Overview
Clinical Trials3
Approvals
News1

Back to Organizations